Old Web
English
Sign In
Acemap
>
authorDetail
>
David Benziger
David Benziger
Cubist Pharmaceuticals
Medicine
Daptomycin
Dosing
Surgery
Pharmacology
6
Papers
484
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairment
2014
Journal of Antimicrobial Chemotherapy
Ricardo L. Chaves
Abhijit Chakraborty
David Benziger
Stacey Tannenbaum
Show All
Source
Cite
Save
Citations (20)
Dosing strategy to allow continued therapy with daptomycin after asymptomatic increases in creatine kinase levels.
2014
American Journal of Health-system Pharmacy
Steven D. Burdette
Frederick B. Oleson
Patrick M. McDaneld
David Benziger
Hina N. Patel
Show All
Source
Cite
Save
Citations (4)
A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
2008
International Journal of Clinical Practice
David E. Katz
Kimberly C. Lindfield
Judith N. Steenbergen
David Benziger
K J Blackerby
Andrew G. Knapp
William J. Martone
Show All
Source
Cite
Save
Citations (80)
Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers
2006
Antimicrobial Agents and Chemotherapy
Mark Benvenuto
David Benziger
Sara Yankelev
Gloria Vigliani
Show All
Source
Cite
Save
Citations (282)
1